Skip to main content
USCOM LIMITED logo

USCOM LIMITED — Investor Relations & Filings

Ticker · UCM ISIN · AU000000UCM2 LEI · 984500B98CA37D7DTC85 ASX Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2020-03-01 Interim / Quarterly Rep…
Country AU Australia
Listing ASX UCM

About USCOM LIMITED

https://www.uscom.com.au/

Uscom Limited specializes in the development and manufacture of non-invasive cardiovascular and pulmonary monitoring devices. Its core product suite includes the Uscom 1A, an ultrasonic cardiac output monitor that provides real-time hemodynamic data for clinical decision-making in emergency, intensive care, and pediatric settings. The company also produces the BP+ system, which utilizes suprasystolic oscillometry to measure central blood pressure and analyze pulse pressure waves, and the SpiroSonic range of digital ultrasonic spirometers designed for high-fidelity pulmonary function testing. These technologies focus on providing accurate, non-invasive diagnostic information to improve patient outcomes in both hospital and home-care environments. By leveraging advanced ultrasonic technology, the company provides clinicians with rapid, reliable physiological data as an alternative to invasive monitoring methods.

Recent filings

Filing Released Lang Actions
Half Yearly Report and Accounts 21 pages 865.9KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX media release titled 'Appendix 4D Results and News' for the half year ended 31 December 2019. It includes detailed financial results, operational summaries, and commentary for the half-year period. The Appendix 4D is a recognized interim financial report format used in Australia, which corresponds to a half-year or interim report. The document contains substantive financial data, including revenue, net loss, cash on hand, and operational updates, as well as an independent review report statement. The length of the document (15,000 characters) and the presence of detailed financial and operational information confirm it is a full interim report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2020
2020-03-01 English
Uscom Investor Update - Coronavirus 26 pages 6.0MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation about Uscom Limited, covering company background, product descriptions, market information, regulatory approvals, sales data, and strategic growth plans. It includes extensive narrative and visual elements about the company's operations, products, and market positioning, but does not contain formal financial statements or regulatory filings. The content is typical of an investor presentation aimed at providing comprehensive information to investors about the company's business and growth prospects. There is no indication that this is an official annual report, earnings release, or regulatory filing. The length and detail also exceed what would be expected for a brief factsheet or announcement. Therefore, the document best fits the category of an Investor Presentation (IP).
2020-02-26 English
USCOM 1A in New International Sepsis Guidelines for Children 3 pages 85.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX media release announcing the inclusion of Uscom's USCOM 1A technology in international pediatric sepsis guidelines. It discusses the technology, its applications, and the company's market position. There is no financial data, no regulatory filing references, no voting results, no management changes, no earnings or annual report content. The document is a public relations announcement about a product and its recognition in medical guidelines. It is not a report, transcript, or regulatory filing. Therefore, it best fits the category of a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2020-02-23 English
New Hubei recommendations for children with Coronavirus 4 pages 233.5KB
Investor Presentation Classification · 90% confidence The document is an ASX media release from Uscom Limited dated February 14, 2020. It discusses new medical recommendations in Hubei for children with Coronavirus and the use of Uscom's medical devices in response to these recommendations. The content focuses on product information, market opportunity, and company strategy related to these new clinical guidelines. There are no financial statements, regulatory certifications, voting results, or management changes. The document is a public announcement intended to inform investors and the market about the impact of new medical guidelines on Uscom's business prospects. It is not a financial report, audit, earnings release, or regulatory filing. Given the nature and length of the document, it fits best as an Investor Presentation (IP) or a Capital/Financing Update (CAP). However, since it is a media release focusing on product and market developments rather than fundraising or capital structure changes, the best fit is Investor Presentation (IP). Confidence is high due to the detailed company and product information and the absence of financial data or regulatory filing characteristics.
2020-02-13 English
Response to ASX Aware Query 5 pages 245.3KB
Regulatory Filings Classification · 95% confidence The document is a letter from the Australian Securities Exchange (ASX) Listings Compliance to Uscom Limited regarding an 'Aware Query' related to continuous disclosure obligations under ASX Listing Rules 3.1 and 3.1A. It discusses the company's prior announcements about sales and orders, clarifies the timing and materiality of information disclosed, and requests detailed responses to specific questions about the company's awareness and disclosure of material information. The document is a regulatory compliance correspondence and does not contain financial statements, earnings data, or management discussion. It is not a report itself but a regulatory inquiry and response related to disclosure obligations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance documents that do not fit other specific categories.
2020-02-11 English
Clarification-Material increase in USCOM 1A orders in China 2 pages 177.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX media release titled 'Market Clarification to ASX Announcement of Material increase in USCOM 1A orders in China'. It provides additional information following a previous announcement and mentions plans to increase manufacturing output and order statistics. The content is focused on clarifying and updating the market about operational and sales developments rather than presenting financial results, management changes, or regulatory filings. It is a market update related to company operations and sales orders, which fits best under Capital/Financing Update (CAP) as it relates to material changes in orders and production plans impacting the company's capital or operational outlook. The document length is 5326 characters, sufficient for a detailed announcement but not a full financial report. There is no indication of financial statements, audit information, or regulatory certifications. Therefore, the classification is CAP with high confidence.
2020-02-10 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.